How We Ranked These
Every food on this list was scored using KibbleIQ’s ingredient analysis rubric, which evaluates protein quality, filler content, preservative safety, and ingredient transparency on a 0–100 scale. For dogs with PLE, we weighted the ACVIM 2023 Consensus Statement on chronic inflammatory enteropathies (Marsilio et al., JVIM), the Dandrieux 2016 JSAP review on canine PLE, Craven 2004 and Kimmel 2000 PLE outcome studies, Okanishi 2014 on hydrolyzed-protein diet response, and Nakashima 2015 on ultra-low-fat nutritional management of lymphangiectasia. PLE is defined by gastrointestinal loss of serum proteins (primarily albumin and globulins) exceeding hepatic synthesis, producing hypoalbuminemia, hypoproteinemia, and downstream edema, ascites, and thromboembolic risk. The three most common underlying etiologies are intestinal lymphangiectasia, chronic inflammatory enteropathy (IBD), and alimentary lymphoma — each requires histopathologic confirmation via intestinal biopsy.
Our ranking leads with therapeutic-tier hydrolyzed-protein diets because the two interventions with strongest evidence for PLE remission per Okanishi 2014 and the 2023 ACVIM consensus are (1) ultra-low-fat feeding (to reduce lymphatic load in lymphangiectasia) and (2) hydrolyzed or novel-protein diets (to reduce antigenic stimulation in immunoproliferative PLE). OTC “limited ingredient” diets rarely achieve the antigen-reduction profile of hydrolyzed formulations, and ultra-low-fat OTC options that also provide complete AAFCO nutrition are essentially nonexistent — which is why therapeutic diets dominate this list.
Our Top 5 Picks
1. Hill’s Prescription Diet z/d Skin/Food Sensitivities — B (76/100)
Hill’s Rx z/d uses hydrolyzed chicken liver protein broken to molecular weights below 10 kDa, which reduces antigenic stimulation of the gut-associated lymphoid tissue (GALT) — the mechanism Okanishi 2014 identified as driving hydrolyzed-diet response in chronic inflammatory enteropathies including PLE. Moderate fat (~13% DM) is not ultra-low but is below maintenance-diet fat levels and may be sufficient for non-lymphangiectasia-dominant PLE. For soft-coated wheaten terriers, Yorkshire terriers, and other breeds with predominantly immunoproliferative PLE rather than primary lymphangiectasia, z/d is the consensus first-line dietary intervention.
Requires veterinary prescription. Use alongside immunosuppression and albumin monitoring — never manage PLE with diet alone. Read our full Hill’s Rx z/d review → · Shop on Amazon →
2. Hill’s Prescription Diet i/d — B (78/100)
For PLE dogs who tolerate intact protein and whose dominant pathology is primary lymphangiectasia rather than immunoproliferative inflammation, Hill’s Rx i/d provides low-fat (~13% DM) highly-digestible nutrition with prebiotic fiber support. The i/d formulation isn’t ultra-low-fat, but when paired with home-prepared ultra-low-fat supplementation (boiled chicken breast, cottage cheese) it can serve as the commercial base of a PLE-appropriate feeding protocol. For Norwegian Lundehunds and Yorkshire terriers where lymphangiectasia dominates, fat restriction is the primary lever and i/d sits at a reasonable compromise point.
For severe lymphangiectasia with albumin <1.5 g/dL, discuss veterinary therapeutic options including custom-formulated ultra-low-fat (<8% DM) diets. Read our full Hill’s Rx i/d review → · Shop on Amazon →
3. Hill’s Prescription Diet w/d Multi-Benefit — B (76/100)
For PLE dogs where fiber-supplement response (colonic bacterial balance, short-chain fatty acid generation) is part of the treatment plan, Hill’s Rx w/d provides elevated fiber (16%+ DM) alongside moderate fat and L-carnitine support. Fiber is not a primary PLE lever the way fat restriction is, but dogs with mixed chronic enteropathy patterns (PLE plus concurrent large-bowel component) sometimes respond better to a fiber-elevated formulation than to pure low-fat GI-support. Discuss with your internist whether fiber therapy is indicated before choosing this path over z/d or i/d.
Not a weight-loss application — in PLE, the weight-management framing of w/d is irrelevant; it’s the fiber and moderate fat that matter. Read our full Hill’s Rx w/d review → · Shop on Amazon →
4. Purina Pro Plan Sensitive Skin & Stomach — B (76/100)
For PLE dogs in long-term remission (albumin stable >2.5 g/dL for 6+ months, off immunosuppression or on minimal maintenance doses) who have tolerated a planned transition off therapeutic diet per veterinary internist guidance, Pro Plan Sensitive Skin & Stomach provides salmon-based moderate-fat nutrition with omega-3 support and prebiotic fiber. This is not a first-line PLE diet — it’s a maintenance option for stabilized dogs whose gastroenterologist has signed off on OTC transition. Attempting to skip therapeutic diets entirely in active PLE is a documented cause of treatment failure.
Only use in PLE dogs with confirmed long-term remission per internist. Not appropriate in active disease. Read our full Pro Plan Sensitive review → · Shop on Amazon →
5. Blue Buffalo Basics Limited Ingredient — B (78/100)
As a potential long-term-remission maintenance option for PLE dogs whose internist has approved OTC transition, Blue Buffalo Basics Limited Ingredient provides novel-protein formulations (duck, turkey, salmon, or lamb) with single-source carbohydrate (potato or pea). The novel-protein approach is adjacent to hydrolyzed-protein reasoning — it reduces antigenic stimulation to proteins the dog hasn’t previously encountered, which may maintain remission after a hydrolyzed-diet response has stabilized the patient. Fat is higher than i/d or z/d, so this is maintenance-only, not active-disease management.
Novel protein only works if the dog hasn’t been exposed — for a dog who’s eaten chicken for years, duck or fish is appropriate; lamb is a poor novel-protein choice for a dog fed lamb-based food previously. Read our full Blue Buffalo Basics review → · Shop on Amazon →
What to Look for in Food for a Dog with Protein-Losing Enteropathy
Confirm the diagnosis and identify the underlying etiology before dietary commitment. PLE is a syndrome, not a diagnosis — underlying etiologies include intestinal lymphangiectasia (dilated/obstructed intestinal lymphatics leaking protein into the gut lumen), chronic inflammatory enteropathy (IBD equivalent), alimentary lymphoma, chronic infection (histoplasmosis, protothecosis), and rarely parasitic disease. Per ACVIM 2023 consensus, histopathologic confirmation via endoscopic or surgical biopsy is required before definitive treatment — different underlying etiologies call for different dietary priorities (ultra-low-fat for lymphangiectasia, hydrolyzed for IBD-driven PLE, chemotherapy plus symptom management for lymphoma).
Ultra-low-fat for primary lymphangiectasia. In intestinal lymphangiectasia, dilated gut lymphatics leak protein-rich lymph into the intestinal lumen whenever lymphatic flow is stimulated — and dietary fat is the strongest stimulant of intestinal lymphatic activity per Nakashima 2015. Target fat restriction below 20 g per 1000 kcal metabolizable energy, ideally 10–15 g/1000 kcal, which corresponds to 5–8% dry-matter fat. Commercial diets in this range are essentially limited to Royal Canin Gastrointestinal Low Fat (not in our reviewed catalog) or home-prepared formulations custom-balanced by a veterinary nutritionist. The ~13% DM fat of Hill’s Rx i/d is “low fat” relative to maintenance diets but is not ultra-low-fat — severe lymphangiectasia often needs lower.
Hydrolyzed or novel protein for immunoproliferative PLE. For immune-mediated PLE where inflammation drives protein loss (common in soft-coated wheaten terriers, Yorkies, chronic enteropathy Labradors), Okanishi 2014 documented stronger remission rates on hydrolyzed-protein diets than on novel-intact-protein alternatives. Hydrolyzed-protein molecular weights below 10 kDa escape detection by the gut immune system, reducing the inflammatory cascade that drives continued protein leak. Hill’s Rx z/d, Royal Canin Hydrolyzed, and Purina Pro Plan HA are the three commercial hydrolyzed options — all three are vet-directed only.
Moderate-to-high protein on a per-calorie basis despite the losing-protein name. Counterintuitively, PLE dogs need elevated dietary protein per calorie because they’re losing serum proteins faster than they can synthesize them — restricting dietary protein worsens hypoalbuminemia. Target 55–75 g protein per 1000 kcal ME, with emphasis on high-biological-value animal protein (or hydrolyzed animal protein where indicated). The therapeutic diets above achieve this through dense protein-per-calorie formulations even with the low-fat macronutrient balance.
Monitor serum albumin as the key clinical marker. Per Craven 2004 and Kimmel 2000, serum albumin below 2.0 g/dL is a prognostic threshold associated with elevated thromboembolic risk (typically pulmonary embolism from antithrombin loss alongside albumin), and albumin below 1.5 g/dL is associated with reduced survival. Dietary changes should be paired with albumin monitoring every 2–4 weeks in active disease and monthly in remission; any dietary modification that doesn’t improve albumin trajectory within 4–6 weeks is not providing clinical benefit and should be reconsidered.
Long-term dietary commitment is usually required. Per Dandrieux 2016, PLE is typically a chronic condition requiring lifelong dietary management even in clinical remission. Attempting to transition off therapeutic diet to maintenance OTC food is a documented cause of relapse in 30–50% of dogs. Long-term feeding of Rx z/d or similar is the realistic expectation for most patients. Budgeting considerations and owner compliance are real practical concerns — discuss with your internist whether a planned maintenance-diet transition is realistic before attempting it.
Bottom Line
Protein-losing enteropathy is a life-threatening chronic condition that requires vet-directed dietary therapy, not OTC food selection. For immunoproliferative PLE (IBD-driven), Hill’s Rx z/d hydrolyzed-protein diet is the first-line dietary intervention. For primary lymphangiectasia, ultra-low-fat feeding is the priority — Hill’s Rx i/d is the closest commercial match, though severe cases may need home-prepared formulations from a veterinary nutritionist. Hill’s Rx w/d adds fiber support when indicated. OTC options (Pro Plan Sensitive, Blue Buffalo Basics LID) are maintenance-only after confirmed long-term remission per internist. Diet is one component of a treatment plan that typically also includes immunosuppression, albumin monitoring, and thromboembolism prevention — never manage PLE with diet alone.